Found: 7
Select item for more details and to access through your institution.
Providing patients with pharmacogenetic test results affects adherence to statin therapy: results of the Additional KIF6 Risk Offers Better Adherence to Statins (AKROBATS) trial.
- Published in:
- Pharmacogenomics Journal, 2014, v. 14, n. 3, p. 272, doi. 10.1038/tpj.2013.27
- By:
- Publication type:
- Article
Experience with voluntary and required genomic data submissions to the FDA: summary report from track 1 of the third FDA-DIA-PWG-PhRMA-BIO pharmacogenomics workshop.
- Published in:
- 2006
- By:
- Publication type:
- Report
The need for education in pharmacogenomics: a regulatory perspective.
- Published in:
- Pharmacogenomics Journal, 2005, v. 5, n. 4, p. 218, doi. 10.1038/sj.tpj.6500316
- By:
- Publication type:
- Article
Pharmacogenetics: From Bench to Bedside.
- Published in:
- Clinical Chemistry & Laboratory Medicine, 2003, v. 41, n. 4, p. 610, doi. 10.1515/CCLM.2003.092
- By:
- Publication type:
- Article
The Emerging Role of Pharmacogenomics in Biologics.
- Published in:
- Clinical Pharmacology & Therapeutics, 2007, v. 82, n. 4, p. 466, doi. 10.1038/sj.clpt.6100334
- By:
- Publication type:
- Article
The Experience with Voluntary Genomic Data Submissions at the FDA and a Vision for the Future of the Voluntary Data Submission Program.
- Published in:
- Clinical Pharmacology & Therapeutics, 2007, v. 81, n. 2, p. 294, doi. 10.1038/sj.clpt.6100053
- By:
- Publication type:
- Article
Adoption of Pharmacogenomic Testing by US Physicians: Results of a Nationwide Survey.
- Published in:
- Clinical Pharmacology & Therapeutics, 2012, v. 91, n. 3, p. 450, doi. 10.1038/clpt.2011.306
- By:
- Publication type:
- Article